JPRN-UMIN000018573已完成2 期
Prospective study of safety and efficacy of additional cryoablation after radiation therapy for malignant lung tumors - Prospective study of cryoablation after radiation therapy for malignant lung tumors
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who are not torelable for radiotherapy and cryoablation therapy.
研究者
相似试验
招募中
2 期
Evaluation of the efficacy and safety of lacosamide to duloxetine in the treatment of taxanes- induced peripheral neuropathyTaxane-induced neuropathy.IRCT20090613002027N21Mazandaran University of Medical Sciences60
已完成
2 期
The Evaluation of Efficacy and Safety of Additional Rituximab (Genetical Recombination) in Refractory Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Patients with Immunoglobulin G4 (IgG4) Autoantibodies in the 2nd Exploratory Clinical Study in Patients Requested Medical CareRefractory Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)Chronicity, Demyelination, Peripheral NeuropathyG618JPRN-jRCTs041210046Katsuno Masahisa5
招募中
不适用
Examination of safety of supplement and usefulness for antioxidant preliminary examination testHealthyJPRN-UMIN000031653IMMUDYNE INC.26
进行中（未招募）
不适用
A trial, in which subjects with type 2 diabetes, who qualify for treatment intensification, are given insulin degludec and, additionally, either liraglutide or insulin aspart, both in combination with metformin, with the largest meal. The purpose is to compare efficacy and safety of these two treatments.Type 2 diabetesMedDRA version: 14.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2011-001493-25-ATovo Nordisk A/S420
进行中（未招募）
不适用
A trial, in which subjects with type 2 diabetes, who qualify for treatment intensification, are given insulin degludec and, additionally, either liraglutide or insulin aspart, both in combination with metformin, with the largest meal. The purpose is to compare efficacy and safety of these two treatments.Type 2 diabetesMedDRA version: 14.0Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2011-001493-25-DEovo Nordisk A/S420